Landscapes / Targets
CD4
5 drugs act on CD4, in 10 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
CD40 ligand (CD40L) antibody |
Eledon Pharmaceuticals · Public ELDN |
Phase 3 | Jan 2027Phase 1/2 trial completes | ||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Kidney Transplant Rejection, Prevention of Rejection in Kidney Transplant | ||||
| Open drug page | |||||
CD44v9-targeted antibody-drug conjugate |
Phase 2/3 | 30 May 2027Phase 1/2 trial completes | |||
| Next date | 30 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Solid Tumors and 2 more | ||||
| Open drug page | |||||
— |
UBP Greater China (Shanghai) +1 |
Phase 2 | Dec 2026Phase 2 trial completes | ||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | HIV-1-infection | ||||
| Open drug page | |||||
— |
Phase 2 | May 2027Phase 2 trial completes | |||
| Next date | May 2027 · Phase 2 trial completes | ||||
| Also tested for | HIV -1 Infection | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2032Phase 2 trial completes | |||
| Next date | Dec 2032 · Phase 2 trial completes | ||||
| Also tested for | Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026